Live feed
Filing
SC 13G
SC 13G0001104659-22-048217·ODRE 2005 SLU
Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: 2022-03-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,108,318
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-048217
- Form type
- SC 13G
- Filer
- ODRE 2005 SLU
- CIK
- CIK 1921938
- Filed
- Apr 21, 2022
- Reporting period
- Mar 18, 2022
- Description
- Schedule 13G beneficial ownership